4-nitroquinoline-1-oxide has been researched along with azacitidine in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altanerová, V | 1 |
| Pechan, R; Schiffmann, D; Stopper, H | 1 |
| Kuratomi, Y; Kuwano, M; Masumi, S; Ono, M; Yasutake, C | 1 |
| Ohta, T; Shiga, Y; Tokishita, S; Watanabe-Akanuma, M; Yamagata, H | 1 |
| Ohta, T; Watanabe-Akanuma, M; Yamagata, H | 1 |
| Albert, M; Gudas, LJ; Scognamiglio, T; Tang, XH | 1 |
| D'Souza, S; Kang, TM; Lam, K; Miller, JH; Song, LY; Yeh, P | 1 |
7 other study(ies) available for 4-nitroquinoline-1-oxide and azacitidine
| Article | Year |
|---|---|
Transformation of BHK 21/13 cells by chemical carcinogens and mutagens.
Topics: 4-Nitroquinoline-1-oxide; Animals; Azacitidine; Benzopyrenes; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cricetinae; Methylcholanthrene; Mutagens; Neoplasms, Experimental; Retroviridae | 1975 |
5-azacytidine induces micronuclei in and morphological transformation of Syrian hamster embryo fibroblasts in the absence of unscheduled DNA synthesis.
Topics: 4-Nitroquinoline-1-oxide; Animals; Azacitidine; Cell Transformation, Neoplastic; Cells, Cultured; Cricetinae; DNA Replication; Dose-Response Relationship, Drug; Embryo, Mammalian; Fibroblasts; Mesocricetus; Micronuclei, Chromosome-Defective; Micronucleus Tests; Mutagenicity Tests; Mutagens | 1992 |
Effect of 5-azacytidine on malignant transformation of a mutant derived from the mouse BALB/c 3T3 cell line resistant to transformation by chemical carcinogens.
Topics: 4-Nitroquinoline-1-oxide; Animals; Azacitidine; Benzo(a)pyrene; Cell Line; Cell Transformation, Neoplastic; DNA; Epidermal Growth Factor; Metallothionein; Methylation; Methylnitronitrosoguanidine; Mice; Mice, Inbred BALB C; Mutation; Proto-Oncogenes; Tetradecanoylphorbol Acetate | 1987 |
Development of new tester strains derived from E. coli WP2uvrA for the determination of mutational specificity.
Topics: 4-Nitroquinoline-1-oxide; Azacitidine; Escherichia coli; Lac Operon; Mutagenicity Tests; Plasmids; Point Mutation; Sodium Azide | 1998 |
A comparison of mutation spectra detected by the Escherichia coli lac(+) reversion assay and the Salmonella typhimurium his(+) reversion assay.
Topics: 2-Aminopurine; 4-Nitroquinoline-1-oxide; Alkylating Agents; Azacitidine; Benzene Derivatives; Cytidine; DNA; DNA Mutational Analysis; Dose-Response Relationship, Drug; Escherichia coli; Ethylnitrosourea; Formaldehyde; Furans; Furylfuramide; Glyoxal; Histidine; Lac Operon; Methylnitronitrosoguanidine; Mutagenicity Tests; Mutagens; Oxidants; Phosmet; Plasmids; Point Mutation; Salmonella typhimurium; Sodium Azide; tert-Butylhydroperoxide; Uracil | 2000 |
A DNA methyltransferase inhibitor and all-trans retinoic acid reduce oral cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Carcinogens; Carcinoma, Squamous Cell; Cyclin-Dependent Kinase Inhibitor p16; Cyclooxygenase 2; Decitabine; DNA Modification Methylases; Female; Immunoenzyme Techniques; Mice; Mice, Inbred C57BL; Mouth Mucosa; Mouth Neoplasms; Proliferating Cell Nuclear Antigen; Proto-Oncogene Proteins c-myb; Receptors, Retinoic Acid; Retinoids; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tretinoin | 2009 |
Exploring Synergy between Classic Mutagens and Antibiotics To Examine Mechanisms of Synergy and Antibiotic Action.
Topics: 2-Aminopurine; 4-Nitroquinoline-1-oxide; Anti-Bacterial Agents; Azacitidine; Bromodeoxyuridine; Chloramphenicol; Ciprofloxacin; Cytidine; DNA Breaks, Double-Stranded; Drug Synergism; Erythromycin; Escherichia coli; Gentamicins; Microbial Sensitivity Tests; Mutagens; Tetracycline; Trimethoprim; Vancomycin | 2015 |